These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
500 related articles for article (PubMed ID: 33514392)
1. CRISPR/Cas9-mediated knockout of clinically relevant alloantigenes in human primary T cells. Kamali E; Rahbarizadeh F; Hojati Z; Frödin M BMC Biotechnol; 2021 Jan; 21(1):9. PubMed ID: 33514392 [TBL] [Abstract][Full Text] [Related]
2. Optimized RNP transfection for highly efficient CRISPR/Cas9-mediated gene knockout in primary T cells. Seki A; Rutz S J Exp Med; 2018 Mar; 215(3):985-997. PubMed ID: 29436394 [TBL] [Abstract][Full Text] [Related]
3. Two Distinct Approaches for CRISPR-Cas9-Mediated Gene Editing in Cryptococcus neoformans and Related Species. Wang P mSphere; 2018 Jun; 3(3):. PubMed ID: 29898980 [No Abstract] [Full Text] [Related]
4. Dynamics of Indel Profiles Induced by Various CRISPR/Cas9 Delivery Methods. Kosicki M; Rajan SS; Lorenzetti FC; Wandall HH; Narimatsu Y; Metzakopian E; Bennett EP Prog Mol Biol Transl Sci; 2017; 152():49-67. PubMed ID: 29150004 [TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells. Mandl M; Ritthammer H; Ejaz A; Wagner SA; Hatzmann FM; Baumgarten S; Viertler HP; Zwierzina ME; Mattesich M; Schiller V; Rauchenwald T; Ploner C; Waldegger P; Pierer G; Zwerschke W Adipocyte; 2020 Dec; 9(1):626-635. PubMed ID: 33070670 [TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 Ribonucleoprotein-mediated Precise Gene Editing by Tube Electroporation. Ma L; Jang L; Chen J; Song J; Yang D; Zhang J; Chen YE; Xu J J Vis Exp; 2019 Jun; (148):. PubMed ID: 31282887 [TBL] [Abstract][Full Text] [Related]
7. Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease. Qin W; Dion SL; Kutny PM; Zhang Y; Cheng AW; Jillette NL; Malhotra A; Geurts AM; Chen YG; Wang H Genetics; 2015 Jun; 200(2):423-30. PubMed ID: 25819794 [TBL] [Abstract][Full Text] [Related]
8. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management. Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Al Abdulmonem W; Moawad AA; Alwanian WM; Almansour NM; Rahmani AH; Khan AA Int J Nanomedicine; 2023; 18():5531-5559. PubMed ID: 37795042 [TBL] [Abstract][Full Text] [Related]
9. CRISPR-mediated TCR replacement generates superior anticancer transgenic T cells. Legut M; Dolton G; Mian AA; Ottmann OG; Sewell AK Blood; 2018 Jan; 131(3):311-322. PubMed ID: 29122757 [TBL] [Abstract][Full Text] [Related]
10. Combination of the clustered regularly interspaced short palindromic repeats (CRISPR)-associated 9 technique with the piggybac transposon system for mouse in utero electroporation to study cortical development. Cheng M; Jin X; Mu L; Wang F; Li W; Zhong X; Liu X; Shen W; Liu Y; Zhou Y J Neurosci Res; 2016 Sep; 94(9):814-24. PubMed ID: 27317429 [TBL] [Abstract][Full Text] [Related]
11. A simple, quick, and efficient CRISPR/Cas9 genome editing method for human induced pluripotent stem cells. Geng BC; Choi KH; Wang SZ; Chen P; Pan XD; Dong NG; Ko JK; Zhu H Acta Pharmacol Sin; 2020 Nov; 41(11):1427-1432. PubMed ID: 32555510 [TBL] [Abstract][Full Text] [Related]
12. Engineering T Cells Using CRISPR/Cas9 for Cancer Therapy. Zhang X; Cheng C; Sun W; Wang H Methods Mol Biol; 2020; 2115():419-433. PubMed ID: 32006414 [TBL] [Abstract][Full Text] [Related]
13. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure. Soriano V AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352 [TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of mouse and human preimplantation development following POU5F1 CRISPR/Cas9 targeting reveals interspecies differences. Stamatiadis P; Boel A; Cosemans G; Popovic M; Bekaert B; Guggilla R; Tang M; De Sutter P; Van Nieuwerburgh F; Menten B; Stoop D; Chuva de Sousa Lopes SM; Coucke P; Heindryckx B Hum Reprod; 2021 Apr; 36(5):1242-1252. PubMed ID: 33609360 [TBL] [Abstract][Full Text] [Related]
15. Rapid, Selection-Free, High-Efficiency Genome Editing in Protozoan Parasites Using CRISPR-Cas9 Ribonucleoproteins. Soares Medeiros LC; South L; Peng D; Bustamante JM; Wang W; Bunkofske M; Perumal N; Sanchez-Valdez F; Tarleton RL mBio; 2017 Nov; 8(6):. PubMed ID: 29114029 [TBL] [Abstract][Full Text] [Related]
16. Efficient Generation of CRISPR/Cas9-Mediated Knockout Human Primary Keratinocytes by Electroporation. Karakaya T; Slaufova M; Di Filippo M; Hennig P; Fenini G; Kündig T; Beer HD Methods Mol Biol; 2024; 2849():73-86. PubMed ID: 38407798 [TBL] [Abstract][Full Text] [Related]
17. Rapid and efficient generation of antigen-specific isogenic T cells from cryopreserved blood samples. Eerkens AL; Vledder A; van Rooij N; Foijer F; Nijman HW; de Bruyn M Immunol Cell Biol; 2022 Apr; 100(4):285-295. PubMed ID: 35194830 [TBL] [Abstract][Full Text] [Related]
18. Self-Cutting and Integrating CRISPR Plasmids Enable Targeted Genomic Integration of Genetic Payloads for Rapid Cell Engineering. Bloemberg D; Sosa-Miranda CD; Nguyen T; Weeratna RD; McComb S CRISPR J; 2021 Feb; 4(1):104-119. PubMed ID: 33616439 [TBL] [Abstract][Full Text] [Related]
19. A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies. Razeghian E; Nasution MKM; Rahman HS; Gardanova ZR; Abdelbasset WK; Aravindhan S; Bokov DO; Suksatan W; Nakhaei P; Shariatzadeh S; Marofi F; Yazdanifar M; Shamlou S; Motavalli R; Khiavi FM Stem Cell Res Ther; 2021 Jul; 12(1):428. PubMed ID: 34321099 [TBL] [Abstract][Full Text] [Related]
20. Development of a CRISPR/Cas9 System for Methylococcus capsulatus Tapscott T; Guarnieri MT; Henard CA Appl Environ Microbiol; 2019 Jun; 85(11):. PubMed ID: 30926729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]